Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.

by Sharon Tregaskis

Facts and Stats

The advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.

by Bradley Jones

From the Editor-in-Chief

Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.

by William G. Nelson, MD, PhD

Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.

by Kendall K. Morgan

A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.

by Ashley P. Taylor

A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.

by Anna Azvolinsky

Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.

by Jon Kelvey

Study underscores importance of early detection and prevention.

by Jane Langille

Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

by Kate Yandell

Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.

by Kevin McLaughlin